Quick Answer

Is there a cure for HIV in 2026?

Answered in plain language, anchored to primary sources.

Last reviewed:

Health information — Educational information, not medical advice. Talk with your healthcare provider about your care and treatment decisions.
← Home
Share this answer Facebook X WhatsApp Text Email LinkedIn Reddit Threads Bluesky

There is no broadly available cure for HIV as of September 2026. Rare, sustained remissions after stem-cell transplantation for serious blood disease provide important research evidence, but transplantation is not routine HIV treatment. ART controls HIV and supports long, healthy lives; it does not eliminate the latent reservoir. Cure research continues.[7][8][9][13]

Rare transplant remissions — and their limits

At AIDS 2024, the “next Berlin patient” was described as the seventh reported cure case after a cancer-related transplant. A later primary report, published online in December 2025 and in Nature in 2026, documented more than six years of remission after ART stopped. Another primary report in April 2026 described the Oslo patient, in remission three years off ART and five years after transplantation for myelodysplastic syndrome.[8][13][1]

These transplants were undertaken for serious blood diseases. Allogeneic transplantation carries substantial risks, including potentially fatal complications, and is not a standard treatment for HIV alone. Follow-up and immunosuppression needs vary.[1]

The second Berlin patient and donor each carried one CCR5Δ32 variant rather than two. This case supports the conclusion that complete CCR5-mediated HIV resistance is not essential for prolonged remission after transplantation. It does not prove that a particular gene-editing method will safely cure HIV in other people.[8][1]

Why treatment is not the same as a cure

CDC is direct about this: there is no cure for HIV, but treatment can reduce the amount of HIV in your body.[2] HIV.gov adds that antiretroviral therapy does not cure HIV and that HIV is still in your body when your viral load is suppressed, even when it is undetectable.[3]

The obstacle has a name. NIH's clinical glossary describes how HIV can remain hidden and inactive — latent — inside immune cells such as CD4 cells for months or years, during which the immune system cannot recognize it and antiretroviral therapy has no effect on it.[4]

The latent reservoir is a major obstacle to cure. When ART stops, HIV usually rebounds, often quickly. Rare post-treatment controllers and documented remissions are exceptions, so “rebound invariably follows” is too absolute. Planned treatment interruption belongs in carefully monitored research or specific medical management, not self-testing for a cure.[14][5]

What is genuinely in the pipeline

Latency-reversing approaches aim to expose previously silent infected cells so that immune-based interventions may help remove them; ART does not simply kill those cells. NIH lists latency reversal, therapeutic vaccines, engineered immune cells, immunotherapies and permanent silencing of HIV among experimental cure strategies. These are research approaches, not approved cures.[9][4]

Long-acting prevention is already available. CDC recommends lenacapavir PrEP for eligible HIV-negative adults and adolescents weighing at least 35 kg, with initiation doses followed by injections every six months. This prevents acquisition through sex; it does not cure HIV in someone who already has it.[6]

Long-acting cabotegravir/rilpivirine is also an HIV treatment option for selected people. NIH’s switch criteria include sustained suppression for at least three months, no relevant known or suspected resistance, and assessment of hepatitis B, pregnancy and drug interactions. Suppression alone does not establish eligibility.[11][2]

How to spot cure misinformation

A product sold as an HIV cure needs credible clinical evidence and regulatory evaluation. No supplement or dietary approach is an approved replacement for ART. Do not stop HIV treatment on the strength of a marketing claim; discuss it with an HIV clinician and check the underlying research.[5]

A transplant remission can be a real scientific advance without being a treatment available for routine HIV care. Check the diagnosis requiring transplantation, time off ART, follow-up duration and whether the findings come from a single case or a larger study.[8][13]

Use trial registries, the original study and current clinical guidance to investigate a claim. A registry listing or conference abstract is not proof that an intervention works, and an unsuccessful search alone does not prove a claim false. The study design, results and independent scrutiny matter.[9]

CDC continues to state that no effective cure is available for routine HIV care, while treatment can control the virus. A claimed cure should not change your treatment plan without review by your HIV care team.[7]

Related questions

Could I get a stem-cell transplant to cure my HIV?

Stem-cell transplantation is not routine treatment for HIV alone. The rare remission cases discussed here involved transplantation for serious blood disease and substantial medical risk. An HIV specialist can explain current treatment and legitimate research options.[1][8][13]

If I am undetectable, am I cured?

No. Maintaining HIV RNA below 200 copies/mL with ART prevents sexual transmission—U=U—but does not remove the latent HIV reservoir. Viral suppression is maintained through treatment; stopping ART can allow rebound.[9][12]

What is a functional cure?

NIH uses sustained ART-free viral remission, sometimes called a functional cure, for long-term control without ongoing ART. Eradication means eliminating the virus entirely and is a different goal. A long-acting medicine still being given is treatment or prevention, not ART-free remission.[9]

Is a vaccine coming?

No preventive HIV vaccine is FDA-approved. Experimental vaccines remain in clinical trials. Lenacapavir PrEP is an antiretroviral medicine with initiation doses and six-month maintenance injections; it is not a vaccine or an HIV cure.[6][10]

Last reviewed: September 2026 by the RiseUpToHIV team. Educational content only — not medical advice.

References & Sources

  1. International AIDS Society — World's seventh HIV cure case following stem cell transplant (AIDS 2024). Documents the seventh person cured of HIV after a stem-cell transplant for leukemia, five-plus years of remission off ART, and that transplants are only used in people with another illness. ↩ ↩ ↩ ↩
  2. CDC — Treating HIV. States there is no cure for HIV, and that injectable treatment requires at least three months of viral suppression. ↩ ↩
  3. HIV.gov — Viral Suppression and an Undetectable Viral Load. States ART does not cure HIV and that HIV remains in the body even when viral load is undetectable. ↩
  4. NIH Clinical Info — Latency-Reversing Agents. Defines HIV latency in CD4 cells as a main obstacle to cure and notes latency-reversing agents are investigational and not FDA approved. ↩ ↩
  5. NIH Office of AIDS Research — Research Toward HIV Cure, reviewed June 17, 2026: reservoirs, remission and experimental strategies. Source. ↩↩
  6. CDC MMWR — Clinical Recommendation for the Use of Injectable Lenacapavir as HIV PrEP. Recommends lenacapavir every six months for people weighing at least 35 kg, a strong recommendation based on high certainty of evidence. ↩ ↩
  7. CDC — About HIV. States there is currently no effective cure for HIV and that HIV can be controlled with proper medical care. ↩ ↩
  8. Gaebler et al. — Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation, Nature; online December 2025, journal issue February 2026. Source. Checked September 21, 2026. ↩ ↩ ↩ ↩ ↩
  9. NIH Office of AIDS Research — Research Toward HIV Cure, June 2026. Source. Checked September 21, 2026. ↩ ↩ ↩ ↩ ↩
  10. NIH HIVinfo — What Is a Preventive HIV Vaccine?. Source. Checked September 21, 2026. ↩
  11. NIH — Optimizing ART in the Setting of Viral Suppression. Source. Checked September 21, 2026. ↩
  12. NIH — ART to Prevent Sexual Transmission. Source. Checked September 21, 2026. ↩
  13. Nature Microbiology — Long-term HIV-1 remission after transplantation from a CCR5Δ32/Δ32 sibling donor, April 2026. Source. Checked September 21, 2026. ↩ ↩ ↩ ↩
  14. NIH — Discontinuation or Interruption of ART. Source. Checked September 21, 2026. ↩

Community publications like POZ, Positively Aware, and TheBody inform framing and lived-experience context on RiseUpToHIV. Every clinical, epidemiological, or public-health claim above is anchored to a primary source.

Search RiseUpToHIV